Dyad gets FDA nod for echocardiography software

By AuntMinnie.com staff writers

August 16, 2022 -- Dyad Medical's Echo:Prio echocardiography image analysis software has secured U.S. Food and Drug Administration (FDA) 510(k) clearance.

Available on the firm's Libby cloud- and artificial intelligence (AI)-based cardiac imaging analysis platform, Echo:Prio analyzes echocardiography images and serves as a decision-making support tool for index quantification of cardiac function, according to the vendor.

Dyad Medical Echo:Prio AI based echocardiography
Dyad Medical's Echo:Prio AI-based echocardiography analysis software. Image courtesy of Dyad.

It can be used from any location on any device and to provide an immediately available second opinion during interpretation, according to Dyad.

Copyright © 2022 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking